Members share how their companies are approaching China's new traceability regulations being phased in after it overhauled its serialization laws and traceability system infrastructure. Healthcare institutions, pharmacies and medical insurance are now required to scan drug traceability codes to manage reimbursement.
Who Can Join?
TraceLink Customers
Meeting Schedule
Time: 9am EDT, 3pm CET, 9pm SGT
Cadence: First Tuesday of the month
Duration: 1 hour
Upcoming Meetings (2026)
2 Jun / 7 Jul / 4 Aug / 1 Sep
Topics from Recent Meetings
- 2026 Drug Administration Law Revisions
- Accessible Product Information: Pilot Phase 6
- NMPA Opinions: Pharmaceutical Distribution
- NMPA Opinions: Contract Manufacturing
- Discussion: Market Access and Coding for Medicines on the Reimbursement List
- Government Plans for Strengthening Drug Supervision and Regulatory Frameworks
- NHSA Deadlines and Requirements for Drug Traceability Code Scanning
- EDMC vs GS1 Product Coding and Supply Chain Compatibility
Join the China Special Interest Group
The 2019 China Drug Administration Law completely revamped the previous regulations, yet some are remaining "stuck" in the old way of doing things. Join fellow members to discuss how to comply with the current regulations, how to connect to the new NMPA system, the pathway to move to GS1 coding, manage the expanded set of reports and data, and provide data to downstream partners. If you're new to China traceability, drop us a note and we can send you an introductory recorded presentation.